Boyan Vesselinov Litchev - 31 Jan 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Reporting relationship: Chief Medical Officer
Issuer ticker: INDP
Reported as of: 31 Jan 2022
Net transaction value: +$2,520
SEC form: 4
Accepted by SEC: 19 Dec 2022, 20:06:32 UTC
Next SEC filing: 02 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Boyan Litchev

Key filing fact

Boyan Vesselinov Litchev filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 19 Dec 2022.

Key facts

This page summarizes Boyan Vesselinov Litchev's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Dec 2022, 20:06.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$2,520.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INDP transaction

Common Stock

Purchase

Transaction value: $465
Shares: +100
Change %
Price: $4.65
Shares after: 100
Date: 31 Jan 2022
Ownership: Direct

INDP transaction

Common Stock

Purchase

Transaction value: $205
Shares: +50
Change %: +50%
Price: $4.09
Shares after: 150
Date: 02 Mar 2022
Ownership: Direct

INDP transaction

Common Stock

Purchase

Transaction value: $915
Shares: +500
Change %: +333%
Price: $1.83
Shares after: 650
Date: 22 Nov 2022
Ownership: Direct

INDP transaction

Common Stock

Purchase

Transaction value: $935
Shares: +500
Change %: +77%
Price: $1.87
Shares after: 1,150
Date: 01 Dec 2022
Ownership: Direct

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .